Skip to main contentAI and Advanced
/
ZOTA · NSEMarket ticker unavailable · configure an authorised index feed
ZO
NSE · Equity shares · Biotechnology & Drugs5.00 · 0.45%
Zota Health Care ZOTA
NSE:INR 1,119
BSE:Not available
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for ZOTA
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,114
Day rangeINR 1,095 — INR 1,119.5
52-week rangeINR 1,022 — INR 1,740
Volume31,804
Market cap4,316.61
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)538.66
Net Income (INR Cr)-73.94
Rev Growth (5 Year %)38.22
Book Value195.02
EPS-21.28
Price/BV5.74Computed
Research path: Interpret Zota Health Care's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
ZOTAZota Health Care1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,131.05 | 439.14 | 228.33 |
| Cash Equivalents | 87.81 | 1.49 | 0.33 |
| Other Liabilities Total | 7.66 | 3.82 | 1.5 |
| Long Term Debt | 6.37 | 4.99 | 0 |
| Common Stock Total | 34.63 | 28.64 | 25.85 |
| Other Current Assets Total | 58.51 | Not available | 0 |
| Total Assets | 1,131.05 | 439.14 | 228.33 |
| Current Portof LT Debt/Capital Leases | 58.14 | 32.05 | 17.44 |
| Cash | 7.77 | 2.13 | 0.68 |
| Total Equity | 693.49 | 223.68 | 89.98 |
| Long Term Investments | 263.88 | 54.35 | 4.7 |
| Retained Earnings(Accumulated Deficit) | 658.86 | -19.19 | -1.75 |
| Total Common Shares Outstanding | 3.46 | 2.86 | 2.58 |
| Tangible Book Valueper Share Common Eq | 195.02 | 76.4 | 33.24 |
| Total Liabilities | 437.56 | 215.46 | 138.35 |
| Total Debt | 270.44 | 139.6 | 95.28 |
| Cashand Short Term Investments | 95.57 | 3.62 | 1 |
| Total Receivables Net | 110.45 | 73.51 | 55.73 |
| Notes Payable/Short Term Debt | 22.36 | 0 | 14.68 |
| Accounts Receivable-Trade Net | 73.52 | 54.61 | 32.48 |
| Property/Plant/Equipment Total-Net | 366.48 | 186.95 | 103.43 |
| Minority Interest | 2.68 | 3.47 | Not available |
| Total Current Liabilities | 237.27 | 100.61 | 73.68 |
| Total Inventory | 192.64 | 105.68 | 53.77 |
| Accounts Payable | 104.6 | 42.4 | 33.61 |
| Other Currentliabilities Total | 52.19 | 14.94 | 3.47 |
| Total Long Term Debt | 189.95 | 107.55 | 63.16 |
| Intangibles Net | 18.09 | 4.92 | 4.07 |
| Other Long Term Assets Total | 25.26 | 8.65 | 4.4 |
| Note Receivable-Long Term | 0.16 | 0.11 | 0.11 |
| Total Current Assets | 457.17 | 184.16 | 111.62 |
| Capital Lease Obligations | 183.58 | 102.55 | 63.16 |
| Accumulated Depreciation Total | Not available | -30.06 | -17.8 |
| Accrued Expenses | Not available | 11.22 | 4.49 |
| Prepaid Expenses | Not available | 1.35 | 1.12 |
| Additional Paid-In Capital | Not available | 214.24 | 65.88 |
| Property/Plant/Equipment Total-Gross | Not available | 211.43 | 116.44 |
| Other Equity Total | Not available | Not available | 0 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m-12.98
Operating Margin 5y Avg-9.69
Net Profit Margin 12m-13.75
Net Profit Margin 5y-11.07
Yield
Dividend Yield %0.08
Valuation
Price to Sale Ratio8.01
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,944 | 4.66 L | 38.87 | — |
| Divi's Laboratories | INR 8,291.55 | 2.20 L | 74.03 | — |
| Torrent Pharmaceuticals | INR 4,965 | 1.89 L | 76.43 | — |
| Cipla | INR 1,475 | 1.19 L | 28.01 | — |
| Zydus Lifesciences | INR 1,106.25 | 1.10 L | 21.29 | — |
Shareholding
Ownership
- Promoter
- 49.38%
- FII
- 7.91%
- MF
- 0.37%
- Other
- 42.34%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Zota Health Care’s <span class='webrupee'>₹</span>350 Crore Fundraise Signals Investor Confidence in Generic Pharma ModelMarket news · 26 Dec 2025, 4:33 pm
Zota Health Care Limited raised ₹ 350 crores from institutional investors through a QIP and appointed MS Dhoni and Suniel Shetty as brand ambassadors. The funds will aid in expanding its network of over 5,000 generic pharmacy stores in India by March 2029.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 15 December 2025Market news · 15 Dec 2025, 6:32 am
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today - Indo Borax and Chemicals, Atlanta Electricals, Zota Health Care, CCL Products (India), and Senores Pharmaceuticals.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 20 November 2025Market news · 20 Nov 2025, 6:36 am
Sumeet Bagadia recommends five breakout stocks to buy today - Sanathan Textiles, KRN Heat Exchanger and Refrigeration, Latent View Analytics, Pearl Global Industries, and Zota Health Care.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 4 November 2025Market news · 4 Nov 2025, 6:37 am
Sumeet Bagadia recommends five breakout stocks to buy today: PDS, Zota Health Care, Remsons Industries, Acutaas Chemicals, and Vijaya Diagnostic Centre.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 28 October 2025Market news · 28 Oct 2025, 7:01 am
Sumeet Bagadia recommends five breakout stocks to buy today: Bharat Seats, Zota Health Care, Precision Wires India, Cartrade Tech, and Parag Milk Foods.
Muhurat Trading 2025 stock picks: Sumeet Bagadia recommends five shares to buy on Samvat 2082Market news · 20 Oct 2025, 4:29 pm
Muhurat Trading 2025 stock picks: Sumeet Bagadia has shared five stock ideas for Muhurat trading tomorrow, namely Zota Health Care, Bharat Seats, Marathon Nextgen Realty, HLE Glascoat and Acutaas Chemicals.
Corporate actions
Events
- dividendRecommended Final Dividend of Re. 1 per equity share.
- board MeetingsTo consider other business matters.
- board MeetingsTo consider other business matters.
- board MeetingsTo consider other business matters.
- annual General MeetingAGM
- dividendRecommended Final Dividend of Re. 1.00 per equity share
- board MeetingsTo consider other business matters.
- board MeetingsTo consider other business matters.
Rusaka Markets Community
Discussion and sentiment for Zota Health Care
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Zota Health Care Limited is an India-based pharmaceutical company, which is engaged in the manufacturing and marketing of pharmaceutical products catering to domestic and international markets. It engages in manufacturing, marketing, and exporting a range of pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company’s business model comprises three verticals, namely Domestic, Exports, and Retail Pharmacy Chain. Its Domestic Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products. Its product portfolio offers over 4,000 therapeutic product categories such as generic, OTC products, allopathic, ayurvedic, and others. Its Retail Pharmacy Chain business operates under the Davaindia brand, which offers a range of private-label products that include pharmaceuticals, nutraceutical, OTC items, and ayurvedic treatments, with a focus on chronic disease management.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- ZOTA
Questions
Stock FAQ
What is the symbol and ISIN of Zota Health Care?
Zota Health Care has the symbol ZOTA and ISIN - INE358U01012.
What is the current price of Zota Health Care?
Zota Health Care is currently trading at INR 1,119.00.
What are the year high and year low of Zota Health Care?
Zota Health Care has a year high of INR 1,740.00 and a year low of INR 1,022.00.
What is the market capitalization of Zota Health Care?
Zota Health Care has a market capitalization of INR 4,316.61 crore.
What is the P/E ratio of Zota Health Care?
Zota Health Care has a P/E ratio of NA.
What is the dividend yield of Zota Health Care?
Zota Health Care has a dividend yield of 0.08%.
How is the financial performance of Zota Health Care based on revenue, net income, and EPS?
Zota Health Care has revenue of INR 538.66 crore, net income of INR -73.94 crore, and EPS of INR -22.61.
What is the book value of Zota Health Care?
Zota Health Care has a book value of INR 195.02.
What is the debt-to-equity ratio of Zota Health Care?
Zota Health Care has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Zota Health Care?
Zota Health Care has a price-to-book ratio of 5.74 and a price-to-sales ratio of 8.01.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.